eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
.
.
.
the state launched a review into the newspaper�s findings in late april.
. updated on:
.
.
.
chronic traumatic encephalopathy (cte), a degenerative brain disease, has been linked by medical researchers to the sort of hits football players endure.
. (image: rex/shutterstock)
.
.
.
he has worked with patients under similar circumstances, but is not involved in the first lady’s case.
.